MITODAC
LIVE

Serial Number

97627312

Owner

Curome Biosciences Co., Ltd.

Attorney

James J. Saul

Filing Date

Oct 11, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MITODAC Trademark

Serial Number: 97627312 • Registration: 7797896

MITODAC is a trademark filed by Curome Biosciences Co., Ltd. on October 11, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Curome Biosciences Co., Ltd.

#A12,194-25, Osongsaengmyeong 1-ro,
Chungcheongbuk-do, 28160 , KR

Entity Type: 03

Trademark Details

Filing Date

October 11, 2022

Registration Date

May 20, 2025

Published for Opposition

April 1, 2025

Goods & Services

Pharmaceutical preparations for treating brain dysfunction; pharmaceutical preparations for treating metabolic disorders; vaccines; pharmaceutical preparations for preventing and treating obesity; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; nutraceuticals for use as a dietary supplement; cardiovascular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical drugs for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical compositions for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceuticals for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations acting on the central nervous system; nutraceutical preparations for therapeutic or medical purposes for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the treatment of degenerative brain disease

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 20, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 20, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 21, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 3, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 3, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 3, 2024 CNSI
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 3, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 3, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 3, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 3, 2024 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 31, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 31, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 31, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 26, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 26, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 26, 2023 CNRT
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 26, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 26, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jul 26, 2023 CNSL
ASSIGNED TO EXAMINER
Jul 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2022 NWOS
NEW APPLICATION ENTERED
Oct 14, 2022 NWAP